September 07, 2017
1 min read
Save

Trial Scorecard: QUIDAM

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Study of whether hydroquinidine can prevent life-threatening ventricular arrhythmias in patients with Brugada syndrome and an implantable cardioverter defibrillator.

Trial Scorecard: QUIDAM